The acquisition of Ypsomed’s pen needles and glucose monitoring systems is expected to increase MTD production capacity to more than 2.5 billion units.
MTD Group Acquires Ypsomed’s Pen Needle and Blood Glucose Monitoring Systems
Leave a comment
